Andrew S Fenning (Andrew Fenning)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 4

Top Topics

Traumatic Brain Injury

Diabetic Nephropathy

Cardiovascular Events

Top Venues

BioMed research international

Molecules (Basel, Switzerland)

Central Queensland University

University of Queensland (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Central Queensland University Jan 01 2005

Australia

Senior Lecturer Pharmacology and Medical Science :: School of Medical and Health Science; Department of Medical Sciences and Imaging

Education History

University of Queensland Feb 01 1996 - Dec 31 2003

Australia

PHD :: Physiology and Pharmacology, Biomedical Sciences

Publications

Matthew I Hiskens, Anthony G Schneiders, Andrew S Fenning
Selective COX-2 Inhibitors as Neuroprotective Agents in Traumatic Brain Injury. Biomedicines 12 (8) (2024)
Matthew I Hiskens, Anthony G Schneiders, Andrew S Fenning
Selective COX-2 Inhibitors as Neuroprotective Agents in Traumatic Brain Injury. Biomedicines 12 (8) (2024)
Douglas J Jackson, Kylie Connolly, Romeo Batacan, Kimberly Ryan, Rebecca K Vella, Andrew S Fenning
(-)-Epicatechin Reduces Blood Pressure and Improves Left Ventricular Function and Compliance in Deoxycorticosterone Acetate-Salt Hypertensive Rats. Molecules (Basel, Switzerland) 23 (7) (2018)
Rebecca K Vella, Douglas J Jackson, Andrew S Fenning
Δ9-Tetrahydrocannabinol Prevents Cardiovascular Dysfunction in STZ-Diabetic Wistar-Kyoto Rats. BioMed research international 2017 (2017)